These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28512665)

  • 1. Involvement of µ-opioid Receptors and κ-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice.
    Takahashi N; Tominaga M; Kosaka R; Kamata Y; Umehara Y; Matsuda H; Sakaguchi A; Ogawa H; Takamori K
    Acta Derm Venereol; 2017 Aug; 97(8):928-933. PubMed ID: 28512665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
    Yamamoto A; Sugimoto Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.
    Ji RR; Zhang Q; Law PY; Low HH; Elde R; Hökfelt T
    J Neurosci; 1995 Dec; 15(12):8156-66. PubMed ID: 8613750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse model of imiquimod-induced psoriatic itch.
    Sakai K; Sanders KM; Youssef MR; Yanushefski KM; Jensen L; Yosipovitch G; Akiyama T
    Pain; 2016 Nov; 157(11):2536-2543. PubMed ID: 27437787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
    Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
    Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal κ- and μ-opioid receptor heterodimerization and female-specific spinal morphine antinociception.
    Liu NJ; Chakrabarti S; Schnell S; Wessendorf M; Gintzler AR
    J Neurosci; 2011 Aug; 31(33):11836-45. PubMed ID: 21849544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of kappa-opioid receptors in visceral nociception in mice.
    Larsson MH; Bayati A; Lindström E; Larsson H
    Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
    Shinohara A; Andoh T; Saiki I; Kuraishi Y
    Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
    Soeberdt M; Kilic A; Abels C
    Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.
    Inan S; Dun NJ; Cowan A
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the mu opioid receptor in the antidepressant effects of buprenorphine.
    Robinson SA; Erickson RL; Browne CA; Lucki I
    Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
    Bigliardi-Qi M; Gaveriaux-Ruff C; Pfaltz K; Bady P; Baumann T; Rufli T; Kieffer BL; Bigliardi PL
    J Invest Dermatol; 2007 Jun; 127(6):1479-88. PubMed ID: 17185983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriasis itch and itch sensitization in mouse.
    Xu Z; Wang Y; Jiang C; Wang Z; Cheng Y; Fan M
    Mol Pain; 2024; 20():17448069241252384. PubMed ID: 38631843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
    Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
    Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of central mu opioid receptors in opioid-induced itch in primates.
    Ko MC; Song MS; Edwards T; Lee H; Naughton NN
    J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis.
    Hashimoto T; Sakai K; Sanders KM; Yosipovitch G; Akiyama T
    Acta Derm Venereol; 2019 Mar; 99(3):298-303. PubMed ID: 30460374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.